Bluerock launched in late 2016 as part of a joint venture between Bayer and the investment firm Versant Ventures. By 2019 Bayer had agreed to buy all the startups equity it didnt already own for 240 million upfront and potentially another 360 million provided Bluerocks programs hit certain development milestones